.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Teva
Harvard Business School
Healthtrust
UBS
Fuji
US Army
Cerilliant
Daiichi Sankyo

Generated: June 23, 2017

DrugPatentWatch Database Preview

CAFCIT Drug Profile

« Back to Dashboard

Which patents cover Cafcit, and when can generic versions of Cafcit launch?

Cafcit is a drug marketed by West-ward Pharms Int and is included in one NDA.

The generic ingredient in CAFCIT is caffeine citrate. There are eleven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the caffeine citrate profile page.

Summary for Tradename: CAFCIT

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list76
Clinical Trials: see list5
Patent Applications: see list24,680
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CAFCIT at DailyMed

Pharmacology for Tradename: CAFCIT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
CAFCIT
caffeine citrate
SOLUTION;INTRAVENOUS020793-001Sep 21, 1999APRXYesYes► Subscribe► Subscribe
West-ward Pharms Int
CAFCIT
caffeine citrate
SOLUTION;ORAL020793-002Apr 12, 2000AARXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
McKinsey
Cantor Fitzgerald
Citi
Teva
Fish and Richardson
Johnson and Johnson
Deloitte
Harvard Business School
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot